Not All Phosphate Is Created Equal

Journal of Renal Nutrition

Volumn 22, Issue 6, 2012, Pages 592-595

  Ketteler, Markus ^a   Westenfeld, Ralf ^b   Ritz, Eberhard ^c  

^a KLINIKUM COBURG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; EDITORIAL; FOOD HANDLING; MEAT; METHODOLOGY; PHOSPHATE INTAKE;

ANIMALS; FOOD HANDLING; MEAT PRODUCTS; PHOSPHORUS, DIETARY;

EID: 84867995105     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2012.02.005     Document Type: Editorial

References (23)

1. Prié D., Ureña Torres P., Friedlander G. Latest findings in phosphate homeostasis. Kidney Int 2009, 75:882-889.
2. Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 2010, 21:1427-1435.
3. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167:879-885.
4. Tonelli M., Sacks F., Pfeffer M., Gao Z., Curhan G. Cholesterol and recurrent events trial investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005, 112:2627-2633.
5. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007, 20:295-301.
6. Cupisti A, Benini O, Ferreti V, Gianfaldoni D, Kalantar-Zadeh K. Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives. J Ren Nutr. In press.
7. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
8. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006, 70:771-780.
9. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005, 16:520-528.
10. Russo D., Miranda I., Ruocco C., et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007, 72:1255-1261.
11. Jono S., McKee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000, 87:E10-E17.
12. Giachelli C.M. The emerging role of phosphate in vascular calcification. Kidney Int 2009, 75:890-897.
13. Moe S.M., O'Neill K.D., Duan D., et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002, 61:638-647.
14. Shroff R.C., McNair R., Skepper J.N., et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010, 21:103-112.
15. Shuto E., Taketani Y., Tanaka R., et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009, 20:1504-1512.
16. Ohnishi M., Razzaque M.S. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 2010, 24:3562-3571.
17. Gutiérrez O.M., Mannstadt M., Isakova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
18. Jean G., Terrat J.C., Vanel T., et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009, 24:2792-2796.
19. Isakova T., Xie H., Yang W., et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011, 305:2432-2439.
20. Seiler S., Cremers B., Rebling N.M., et al. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 2011, 32:2688-2696.
21. Faul C., Amaral A.P., Oskouei B., et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011, 121:4393-4408.
22. Gutiérrez O.M., Anderson C., Isakova T., et al. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 2010, 21:1953-1960. CRIC Study Group.
23. Grases F., Sanchis P., Perello J., et al. Phytate (myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci 2006, 11:136-142.